Nymox Pharmaceutical Corporation (NYMX) Dividend History
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Last update 11/29/2020
Dividend Yield Summary
|Date||Amount Per Share||Note|